Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Stark AK"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stark AK; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA. Electronic address: Amy.K.Stark@Vanderbilt.edu., Penn JS; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA; Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Publikováno v:
Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2024 Oct; Vol. 174, pp. 106864. Date of Electronic Publication: 2024 Jun 30.
Autor:
Bonder MJ; Division of Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany. bonder.m.j@gmail.com.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. bonder.m.j@gmail.com.; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. bonder.m.j@gmail.com.; Oncode Institute, Utrecht, The Netherlands. bonder.m.j@gmail.com., Clark SJ; Altos Labs, Cambridge Institute of Science, Cambridge, UK. sclark@altoslabs.com.; Epigenetics Programme, The Babraham Institute, Cambridge, UK. sclark@altoslabs.com., Krueger F; Altos Labs, Cambridge Institute of Science, Cambridge, UK.; Bioinformatics Group, The Babraham Institute, Cambridge, UK., Luo S; Laboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Agostinho de Sousa J; Laboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Hashtroud AM; Max Planck Institute for the Physics of Complex Systems, Dresden, Germany.; Arnold Sommerfeld Center for Theoretical Physics and Center for NanoScience, Department of Physics, Ludwig-Maximilians-Universität, Munich, Germany., Stubbs TM; Epigenetics Programme, The Babraham Institute, Cambridge, UK.; Chronomics Limited, London, UK., Stark AK; Immunology Programme, The Babraham Institute, Cambridge, UK., Rulands S; Max Planck Institute for the Physics of Complex Systems, Dresden, Germany.; Arnold Sommerfeld Center for Theoretical Physics and Center for NanoScience, Department of Physics, Ludwig-Maximilians-Universität, Munich, Germany., Stegle O; Division of Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany., Reik W; Altos Labs, Cambridge Institute of Science, Cambridge, UK. wreik@altoslabs.com.; Epigenetics Programme, The Babraham Institute, Cambridge, UK. wreik@altoslabs.com.; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. wreik@altoslabs.com., von Meyenn F; Laboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. ferdinand.vonmeyenn@hest.ethz.ch.; Department of Medical and Molecular Genetics, King's College London, London, UK. ferdinand.vonmeyenn@hest.ethz.ch.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 31; Vol. 15 (1), pp. 7567. Date of Electronic Publication: 2024 Aug 31.
Autor:
Blackmore K; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Houchen CJ; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Simonyan H; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Arestakesyan H; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Stark AK; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Dow SA; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Kim HR; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Jeong JK; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA., Popratiloff A; Nanofabrication and Imaging Center, George Washington University, Washington, DC, 20037, USA., Young CN; Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 20037, USA. Electronic address: colinyoung@gwu.edu.
Publikováno v:
Molecular metabolism [Mol Metab] 2024 Jan; Vol. 79, pp. 101858. Date of Electronic Publication: 2023 Dec 21.
Autor:
Pantarelli C; Signalling Programme., Pan D; Signalling Programme., Chetwynd S; Signalling Programme., Stark AK; Lymphocyte Signalling Programme., Hornigold K; Signalling Programme., Machin P; Signalling Programme., Crossland L; Signalling Programme., Cleary SJ; Signalling Programme., Baker MJ; Signalling Programme., Hampson E; Signalling Programme., Mandel A; Signalling Programme., Segonds-Pichon A; Bioinformatics Group, and., Walker R; Flow Cytometry Facility, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., van 't Veer C; Center of Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and., Riffo-Vasquez Y; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Okkenhaug K; Lymphocyte Signalling Programme., Pitchford S; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Welch HCE; Signalling Programme.
Publikováno v:
Blood advances [Blood Adv] 2021 Aug 24; Vol. 5 (16), pp. 3076-3091.
Autor:
Iacono A; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Pompa A; Department of Biomolecular Sciences, University Carlo Bo, Urbino, Italy.; Institute of Biosciences and Bioresources, National Research Council of Italy, Perugia, Italy., De Marchis F; Institute of Biosciences and Bioresources, National Research Council of Italy, Perugia, Italy., Panfili E; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Greco FA; Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy., Coletti A; Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy., Orabona C; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Volpi C; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Belladonna ML; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Mondanelli G, Albini E; Department of Experimental Medicine, University of Perugia, Perugia, Italy.; Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy., Vacca C; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Gargaro M; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Fallarino F; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Bianchi R; Department of Experimental Medicine, University of Perugia, Perugia, Italy., De Marcos Lousa C; Centre for Biomedical Sciences, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, UK.; Center for Plant Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK., Mazza EM; Istituto Clinico Humanitas, Rozzano, Italy., Bicciato S; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy., Proietti E; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Milano F; Department of Medicine, University of Perugia, Perugia, Italy., Martelli MP; Department of Medicine, University of Perugia, Perugia, Italy., Iamandii IM; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Graupera Garcia-Mila M; Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Spain., Llena Sopena J; Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Spain., Hawkins P; Babraham Institute, Cambridge, UK., Suire S; Babraham Institute, Cambridge, UK., Okkenhaug K; Department of Pathology, University of Cambridge, Cambridge, UK., Stark AK; Department of Pathology, University of Cambridge, Cambridge, UK., Grassi F; Institute for Research in Biomedicine, Bellinzona, Switzerland., Bellucci M; Institute of Biosciences and Bioresources, National Research Council of Italy, Perugia, Italy., Puccetti P; Department of Experimental Medicine, University of Perugia, Perugia, Italy., Santambrogio L; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Macchiarulo A; Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy., Grohmann U; Department of Experimental Medicine, University of Perugia, Perugia, Italy.; Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA., Pallotta MT; Department of Experimental Medicine, University of Perugia, Perugia, Italy.
Publikováno v:
EMBO reports [EMBO Rep] 2020 Dec 03; Vol. 21 (12), pp. e49756. Date of Electronic Publication: 2020 Nov 07.
Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
Autor:
Stark AK; Laboratory of Lymphocyte Signalling and Development, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom., Davenport ECM; Laboratory of Lymphocyte Signalling and Development, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.; Royal Veterinary College, London NW1 0TU, United Kingdom., Patton DT; Laboratory of Lymphocyte Signalling and Development, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom., Scudamore CL; Royal Veterinary College, London NW1 0TU, United Kingdom.; Exepathology, Exmouth EX8 5LQ, United Kingdom., Vanhaesebroeck B; UCL Cancer Institute, University College London, London WC1E 6AG, United Kingdom., Veldhoen M; Laboratory of Lymphocyte Signalling and Development, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.; Instituto de Medicina Molecular, Joâo Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisbon, Portugal; and., Garden OA; Royal Veterinary College, London NW1 0TU, United Kingdom.; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104., Okkenhaug K; Laboratory of Lymphocyte Signalling and Development, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom; ko256@cam.ac.uk.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2020 Jul 01; Vol. 205 (1), pp. 78-89. Date of Electronic Publication: 2020 May 15.